Phase 1 Data Highlight RE104 Favorable Safety Profile and Short Duration Psychoactive Experience ---- Topline Results from RECONNECT Phase 2 Trial of RE104 in Postpartum Depres ...

Some women’s symptoms improved quickly after taking the pill, but depression persisted in others. Doctors are trying to learn which patients benefit, and why some don’t.

Postpartum can be a dangerous time for new moms — nearly two in three maternal deaths occur in the first year after birth, per the Centers for Disease Control and Prevention (CDC). Meeting with your ...

Learn about the increasing postpartum depression (PPD) rates among Black women and the challenges they face in the medical system.

Mothers experiencing depression have considerable challenges across multiple parenting domains, according to a global ...

A comprehensive global review confirms that maternal depression undermines parenting, impairing mother-infant bonding and ...

A new study shows that oxytocin nasal spray helps mothers with postpartum depression interact more positively with their babies.

Design: Mothers indicated mid-pregnancy and six month postpartum depressive symptoms on the Edinburgh postpartum depression scale (EPDS). Associations of sociodemographic factors with odds of scoring ...

When she took the Edinburgh Postnatal Depression Scale (EPDS), a tool used to screen for postpartum depression, she felt even ...

Postpartum depression was determined by hospital codes indicating a mood disorder, a prescription for an antidepressant medication, or a positive screen on the Edinburgh Postnatal Depression Scale ...

Researchers have developed a new machine learning model that can evaluate a patient's risk of developing postpartum depression based on readily accessible clinical and demographic factors.

Key Points: 1. In a randomized controlled trial, use of Woebot, a mental health chatbot, significantly reduced symptoms of postpartum depression and anxiety compared to waitlist controls. 2.